FDA partners with advocacy groups, research organizations to fight Alzheimer's

04/10/2014 | FDA Voice blog

Hamburg

As society comes to grips with the personal, economic and social effects of Alzheimer's disease, the FDA remains determined to facilitate the discovery of effective treatments, FDA Commissioner Dr. Margaret Hamburg writes. The agency is participating in efforts to create a national plan to address the Alzheimer's disease crisis and is partnering on public-private initiatives and with advocacy groups and consortia in the Alzheimer’s community, she writes.

View Full Article in:

FDA Voice blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC